CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Affymetrix, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Affymetrix, Inc.
3420 Central Expy
Phone: (408) 731-5000p:408 731-5000 SANTA CLARA, CA  95051-0703  United States Ticker: AFFXAFFX

This company was Merged or Acquired on 3/31/2016.
This company ceased filing statements with the SEC on 4/15/2016.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
Affymetrix, Inc. is a provider of life science products and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein and cell level. The Company sells its products to genomic research centers, academic institutions, government and private laboratories, as well as pharmaceutical, diagnostic and biotechnology companies. The Company maintains sales and distribution operations across the United States, Europe, Latin America and Asia. It operates in two business segments: Affymetrix Core and eBioscience. Affymetrix Core focuses on the development, manufacture and commercialization of systems for genetic analysis in the life sciences, agricultural biotechnology (AgBio) and diagnostic industries. eBioscience primarily focuses on the development, manufacture, marketing and distribution of research products in the areas of flow cytometry, immunoassays, microscopic imaging and other protein-based analyses.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/201512/31/2015YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairwoman of the Board Jami K.Nachtsheim 56 1/30/2015 3/8/2010
President, Chief Executive Officer, Director Franklin R.Witney 61 7/1/2011 2/10/2009
Chief Financial Officer, Executive Vice President GavinWood 45 5/20/2013 5/20/2013
7 additional Officers and Directors records available in full report.

Business Names
Business Name
AFFX
Affymetrix Biotech Ltda.
Affymetrix Biotech Shanghai Ltd.
13 additional Business Names available in full report.

General Information
Number of Employees: 1,150 (As of 12/31/2015)
Outstanding Shares: 80,541,254 (As of 2/11/2016)
Shareholders: 235
Stock Exchange: NASD
Federal Tax Id: 770319159
Fax Number: (408) 731-5380
Email Address: investor@affymetrix.com


Copyright © 2021 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, March 17, 2021